AGF Investments America’s Bristol-Myers Squibb BMY Stock Holding History

AGF Investments America’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-94,953	Closed	-$6.93M	–	31
2022 Q1	$6.93M	Buy	94,953 +45,275	+91%	+$3.04M	1.26%	34
2021 Q4	$3.1M	Buy	49,678 +1,182	+2%	+$69.3K	0.59%	43
2021 Q3	$2.87M	Hold	48,496	–	–	0.6%	45
2021 Q2	$3.24M	Buy	48,496 +1,031	+2%	+$67.2K	0.77%	43
2021 Q1	$3M	Hold	47,465	–	–	0.76%	44
2020 Q4	$2.94M	Buy	47,465 +45	+0.1%	+$2.77K	0.76%	44
2020 Q3	$2.86M	Buy	47,420 +574	+1%	+$34.5K	0.86%	39
2020 Q2	$2.75M	Buy	46,846 +1,587	+4%	+$94.9K	0.94%	38
2020 Q1	$2.52M	Buy	45,259 +645	+1%	+$39.4K	1.05%	34
2019 Q4	$2.86M	Buy	44,614 +395	+0.9%	+$22.6K	0.94%	38
2019 Q3	$2.24M	Buy	44,219 +848	+2%	+$39.9K	0.75%	42
2019 Q2	$1.97M	Buy	43,371 +10,883	+33%	+$507K	0.67%	48
2019 Q1	$1.55M	Buy	32,488 +2,157	+7%	+$107K	0.55%	51
2018 Q4	$1.58M	Buy	30,331 +733	+2%	+$39.4K	0.64%	45
2018 Q3	$1.84M	Buy	29,598 +489	+2%	+$29K	0.64%	50
2018 Q2	$1.61M	Buy	29,109 +675	+2%	+$36.5K	0.59%	52
2018 Q1	$1.8M	Buy	28,434 +520	+2%	+$33.5K	0.68%	49
2017 Q4	$1.71M	Buy	27,914 +754	+3%	+$47.2K	0.64%	47
2017 Q3	$1.73M	Buy	27,160 +335	+1%	+$19.6K	0.66%	48
2017 Q2	$1.5M	Buy	26,825 +956	+4%	+$52K	0.59%	51
2017 Q1	$1.41M	Buy	25,869 +433	+2%	+$23.7K	0.58%	54
2016 Q4	$1.49M	Buy	25,436 +317	+1%	+$17.3K	0.63%	53
2016 Q3	$1.35M	Buy	25,119 +90	+0.4%	+$5.78K	0.59%	52
2016 Q2	$1.84M	Buy	+25,029	New	+$1.77M	0.83%	44

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AGF Investments America's BMY Position: Q2 2022 in Review

AGF Investments America sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 94,953 shares — an estimated $6.93M sold.

AGF Investments America first reported a position in BMY in Q2 2016 and held it in 24 quarters. The position peaked at $6.93M in Q1 2022. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

AGF Investments America reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
AGF Investments America sold 94,953 Bristol-Myers Squibb shares in Q2 2022, an estimated $6.93M.
AGF Investments America first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 24 quarters.
AGF Investments America's Bristol-Myers Squibb position peaked at $6.93M in Q1 2022.
2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on AGF Investments America's 13F filing for Q2 2022, filed 12 Aug 2022.